References
1a
Bleckmann W.
Hanack M.
Chem. Ber.
1984,
117:
3021
1b
Froehler BC.
Wadwani S.
Terhorst TJ.
Gerrard SR.
Tetrahedron Lett.
1992,
33:
5307
1c
Tanaka H.
Baba M.
Hayakawa H.
Sakamaki T.
Miyasaka T.
Ubasawa M.
Takashima H.
Sekiya K.
Nitta I.
J. Med. Chem.
1991,
34:
349
1d
Makra F.
Rohloff JC.
Muehldorf AV.
Link JO.
Tetrahedron Lett.
1995,
36:
6815
1e
Awano H.
Shuto S.
Miyashita T.
Ashida N.
Machida H.
Arch. Pharm.
1996,
329:
66
1f
Blough BE.
Abraham P.
Lewin AH.
Kuhar MJ.
Boja JW.
Carroll FI.
J. Med. Chem.
1996,
39:
4027
1g
Kuyper LF.
Baccanari DP.
Jones ML.
Hunter RN.
Tansik RL.
Joyner SS.
Boytos CM.
Rudolph SK.
Knick V.
Wilson HR.
Caddell JM.
Friedman HS.
Comley JCW.
Stables JN.
J. Med. Chem.
1996,
39:
892
1h
Cushman M.
He H.-M.
Katzenellenbogen JA.
Varma RK.
Hamel E.
Lin CM.
Ram S.
Sachdeva YP.
J. Med. Chem.
1997,
40:
2323
1i
Kloppenburg L.
Song D.
Bunz UHF.
J. Am. Chem. Soc.
1998,
120:
7973
1j
Xu L.
Lewis IR.
Davidsen SK.
Summers JB.
Tetrahedron Lett.
1998,
39:
5159
1k
Ostrowski T.
Wroblowski B.
Busson R.
Rozenski J.
De Clercq E.
Bennett MS.
Champness JN.
Summers WC.
Sanderson MR.
Herdewijn P.
J. Med. Chem.
1998,
41:
4343
1l
Pschirer NG.
Bunz UHF.
Tetrahedron Lett.
1999,
40:
2481
1m
Froehler BC.
Wadwani S.
Terhorst TJ.
Gerrard SR.
Tetrahedron Lett.
1992,
33:
5307
1n
Sakamoto T.
An-naka M.
Kondo Y.
Yamanaka H.
Chem. Pharm. Bull.
1986,
34:
2754
1o
Al-Hassan MI.
J. Organomet. Chem.
1990,
395:
227
1p
Bleckmann W.
Hanack M.
Chem. Ber.
1984,
117:
3021
2
Jauch J.
Schmalzing D.
Schurig V.
Emberger R.
Hopp R.
Köpsel M.
Silberzahn W.
Werkhoff P.
Angew. Chem., Int. Ed. Engl.
1989,
28:
1022
3a
Suffert J.
Toussaint D.
J. Org. Chem.
1995,
60:
3550
3b
Toussaint D.
Suffert J.
Organic Synthesis
1999,
76:
214
4a
Fritsch P.
Liebigs Ann. Chem.
1894,
272:
319
4b
Buttenberg WP.
Liebigs Ann. Chem.
1894,
272:
324
4c
Wiechell H.
Liebigs Ann. Chem.
1894,
272:
337
5
Sonogashira K.
Toha Y.
Hagihara N.
Tetrahedron Lett.
1975,
4467
6 Representative Procedure (Table, Entry 2):
[2,2-Dimethyl-5-(2-pent-1-en-3-ynyl-phenyl)-[1,3]dioxolan -4-ylethynyl]-trimethyl-silane: A solution of nBuLi (1.8 mL, 1.54 M in hexane, 2.73 mmol, 2.2 equiv) was slowly added to a cooled solution of (Z/E)-1-bromopropene (0.233 g, 1.92 mmol, 1.55 equiv) in anhydrous THF (2.5 mL) under argon. This solution was stirred at -78 °C during 2 hours. H2O (0.05 mL, 2.73 mmol, 2.2 equiv) was then added in one portion at -78 °C via syringe and the reaction mixture warmed to 0 °C. The halogenated substrate (0.470 g, 1.24 mmol, 1 equiv) dissolved in THF (2 mL) was added via syringe to the propyne solution, followed by Pd(Ph3P)2Cl2 (43.5 mg, 0.062 mmol, 0.05 equiv), CuI (23.6 mg, 0.124 mmol, 0.1 equiv) and iPr2NH (2.2 mL). The temperature was raised to 20 °C and the reaction followed by TLC. Then the reaction was quenched with 20 mL of a saturated NH4Cl in water and extracted with the appropriate solvent (3 × 10 mL). The organic phase was dried over Na2SO4, decolored by charcoal, filtered and the solvent was removed under reduce pressure. The crude propynylated product was purified by flash chromatography (1:99, ether-hexane) on silica gel to give the desired compound (0.418 g 98%). 1H NMR (200 MHz, CDCl3) δ 0.21 (s, 9 H, Si(CH3)3); 1.61 (s, 3 H,); 1.62 (s, 3 H); 2.01 (d, 3 H, J = 2.4 Hz); 4.38 (d, 1 H, J = 7.9 Hz); 5.38 (d, 1 H, J = 7.9 Hz); 6.05 (dq, 1 H, J
trans = 16 Hz, 5
J = 2.4 Hz); 7.25-7.38 (m, 2 H, arom. H); 7.47 (d, 1 H, J
trans = 16 Hz); 7.43-7.57 (m, 2 H, arom. H). 13C NMR (50 MHz, CDCl3): δ 0.44 [Si(CH3)3]; 4.5, 26.3, 26.8, 73.1, 79.2, 79.4, 88.5, 93.3, 100.8, 110.4, 111.5, 125.6, 126.2, 128.4, 128.5, 134.0, 135.6, 137.2. IR (CHCl3, cm-1) 3668 (w); 3026 (m, CH); 2991 (m, CH); 2962 (s); 2918 (m); 2217 (m); 2177 (m, C≡C); 1600 (m); 1453 (m); 1383 (w); 1255 (w); 1210 (w); 1163 (w); 1100 (w); 1052 (w); 990 (w); 956 (m).